BRNS
Barinthus Biotherapeutics
BRNS
BRNS
15 hedge funds and large institutions have $36.6M invested in Barinthus Biotherapeutics in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 16 → 15 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
15
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$43.2K | |
| 2 | +$41.2K | |
| 3 | +$30.7K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.38K |